Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
12/2008
12/02/2008US7459568 To Treat arthrosis, osteoporosis; improved characteristics in terms of filtration and ease of formulation for oral administration; storage stability; distrontium salt of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and its hydrates
12/02/2008US7459567 Substituted thienyl and furyl acylguanidines and methods of their use as beta-secretase modulators
12/02/2008US7459558 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
12/02/2008US7459477 Chemical intermediate for agriculture, horticulture compounds; insecticide, fungicides, miticides
12/02/2008US7459414 Herbicides
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008143777A1 Hydroquinone derivative skin brightening compounds
11/27/2008WO2008143229A1 Anthracene derivative and organic electroluminescent device using the same
11/27/2008WO2008141980A1 Substituted amino-thiourea compounds for combating animal pests
11/27/2008WO2007136790A3 Intracellular kinase inhibitors
11/27/2008US20080293952 Method for the Preparation of (S)-N-Methyl-3-(1-Naphthyloxy)-3-(2-Thienyl)Propylamine Hydrochloride (Duloxetine)
11/27/2008DE102007023747A1 Organisches elektrochromes Bauelement für Daueranzeigen Organic electrochromic device for continuous displays
11/26/2008EP1740568B1 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease.
11/26/2008CN101312959A Novel thiophene derivatives
11/26/2008CN100436425C Fused imidazolium derivatives
11/25/2008US7456218 3-(4-{[4'-(benzyloxy)-2',6'-dimethylbiphenyl-3-yl]methoxy}-2-fluorophenyl)propanoic acid; superior GPR40 receptor function modulating action, can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008107911A3 Novel process for preparation of duloxetine hydrochloride
11/20/2008WO2008081476A3 Process for preparing duloxetine hydrochloride
11/20/2008WO2008068617A3 Photoactive compounds
11/20/2008US20080287693 Process for the Preparation of 1-Naphthol Mixed Ethers and Intermediates of Crystalline Forms of (+) and (-)-Duloxetine
11/20/2008US20080287692 Synthesis of cyclopentadiene derivatives
11/20/2008US20080287489 Ophthalmic compositions for treating ocular hypertension
11/20/2008US20080287450 Novel Substituted Tetracyclic Tetahydrofuran, Pyrrolidine And Tetrahydrothiophene Derivatives
11/20/2008US20080286693 Sulfonate derivatives and the use thereof as latent acids
11/19/2008EP1991514A1 Novel anthracene derivative and organic electronic device using the same
11/19/2008EP1991226A2 Inhibitors of histone deacetylase
11/19/2008EP1991220A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease
11/19/2008EP1692093B1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008CN101309902A Biphenyl derivatives and their use in treating hepatitis c
11/19/2008CN101306968A Process for synthesizing halogenated compounds by oxygenizing and halogenating reaction
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/18/2008CA2561590C Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues
11/18/2008CA2395481C Hormone receptor modulation
11/18/2008CA2344057C Treatment of persistent pain
11/18/2008CA2340912C Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008113760A3 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes
11/13/2008US20080281095 Asparatyl protease inhibitor
11/13/2008US20080280956 Heteroarylsulfonyl Stilbenes as 5-Ht2a Antagonists
11/13/2008US20080280905 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
11/13/2008CA2685389A1 Tricyclic compounds as matrix metalloproteinase inhibitors
11/12/2008EP1989193A1 Process for obtaining enantiomers of duloxetine precursors
11/12/2008EP1893597B1 Ampa receptor potentiators
11/12/2008EP1727808B1 Biaryl amino acids and their use in dna binding oligomers
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008CN101304986A Regioselective process for preparing benzimidazole thiophenes
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN100432837C Thiopene-containing photo acid generators for photolithography
11/12/2008CN100432069C 3-methylamino-1-(2-thienyl)-1-propanone, production and use thereof
11/12/2008CN100432068C Alkynyl thiofuran compound and its prepn and application
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/11/2008US7449588 by treatment with basic compounds consisting of calcium oxide, magnesium oxide, barium oxide, aluminium oxide, oxide hydroxides thereof and mixtures; to avoid the changes in color or formation of secondary components
11/11/2008US7449580 Ticlopidine and clopidogrel simply prepared by reacting a substituted thiophene derivative with a 2-chlorobenzylamine derivative
11/11/2008US7449490 Pharmaceutically active compounds and methods of use
11/11/2008US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/06/2008WO2008132925A1 Method for producing 3-aminothiophene
11/06/2008WO2008131946A2 Substituted amide derivatives
11/06/2008WO2008116663A3 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275100 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient
11/06/2008US20080275066 3-Methanesulfonyl-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylic acid 2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl ester; for treatment of metabolic disorders such as IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity
11/06/2008DE102007020493A1 Substituierte Amid-Derivate Substituted amide derivatives
11/06/2008DE102007020492A1 Substituierte Sulfonamid-Derivate Substituted sulfonamide derivatives
11/06/2008CA2685503A1 Substituted amide derivatives
11/05/2008EP1987811A1 Skin-whitening cosmetic
11/05/2008EP1987013A1 Bicyclic sphingosine 1-phosphate analogs
11/05/2008EP1986638A2 Cb1 antagonists and inverse agonists
11/05/2008EP1534276B1 Non-nucleoside reverse transcriptase inhibitors
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008CN101300247A 3-hydroxymethylbenzo[b]thiophene derivative and method for producing same
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446236 Catalytic hydrogenation of carbon-heteroatom double bonds
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446219 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/04/2008US7446213 Cationic, water-soluble polythiophene derivatives, which can readily transduce oligonucleotide hybridization into a clearly interpretable optical (colorimetric, fluorescent or luminescent) or electrical signal
11/04/2008CA2256328C Novel n-acylsulphonamides, novel mixtures of herbicides and antidotes and their use
11/04/2008CA2229183C Endothelin antagonist
10/2008
10/30/2008WO2008130508A1 Indanone derivatives that inhibit prolyl hydroxylase
10/30/2008WO2008130323A1 Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain
10/30/2008WO2008128321A1 Therapeutic pro-antibiotic agents and methods of use thereof
10/30/2008WO2008064320A3 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
10/30/2008WO2008057497A3 Small organic molecule regulators of cell proliferation
10/30/2008WO2008022204A3 Thiourea compounds
10/30/2008US20080269506 Chemical amplification type resist composition
10/30/2008US20080269481 N-heterocyclyl- or cycloalkyl-N-(2-carboxy-5-aryl-3-thiophenyl)cycloalkanecarboxamides, e.g., 5-(3-fluorophenyl)-3-[isopropyl-(4-methylcyclohexanecarbonyl)amino]-thiophene-2-carboxylic acid; especially for prevention and treatment of HVC
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269283 Arylsulfones and uses related thereto
10/30/2008US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group
10/30/2008US20080269221 Antibacterial agents
10/30/2008CA2683512A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
10/29/2008EP1984347A1 Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
10/29/2008EP1984346A1 Processes for the preparation of crystalline forms of duloxetine hydrochloride
10/29/2008EP1984340A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 329